Themis Medicare Limited

NSE:THEMISMED.NS

263.45 (INR) • At close November 1, 2024
Bedrijfsnaam Themis Medicare Limited
Symbool THEMISMED.NS
Munteenheid INR
Prijs 263.45
Beurswaarde 24,247,964,345
Dividendpercentage 0.24%
52-weken bereik 142 - 303
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Sachin Dinesh Patel CChem., Ph.D.
Website https://www.themismedicare.com

An error occurred while fetching data.

Over Themis Medicare Limited

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations for use in various therapeutic areas, including anti-infective, antimalarial, anti-tuberculosis, cardiology, health and nutrition, oncology, ophthalmology, and pain management. The company was formerly known as Themis Chemicals

Vergelijkbare Aandelen

SMS Pharmaceuticals Limited logo

SMS Pharmaceuticals Limited

SMSPHARMA.NS

300.65 INR

Vimta Labs Limited logo

Vimta Labs Limited

VIMTALABS.NS

572.8 INR

Jagsonpal Pharmaceuticals Limited logo

Jagsonpal Pharmaceuticals Limited

JAGSNPHARM.NS

549.55 INR

Zota Health Care Limited logo

Zota Health Care Limited

ZOTA.NS

610.1 INR

Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited

BLISSGVS.NS

127 INR

RPG Life Sciences Limited logo

RPG Life Sciences Limited

RPGLIFE.NS

2,621.45 INR

Sigachi Industries Limited logo

Sigachi Industries Limited

SIGACHI.NS

50.55 INR

Panacea Biotec Limited logo

Panacea Biotec Limited

PANACEABIO.NS

347.9 INR

Nectar Lifesciences Limited logo

Nectar Lifesciences Limited

NECLIFE.NS

38.98 INR

Lincoln Pharmaceuticals Limited logo

Lincoln Pharmaceuticals Limited

LINCOLN.NS

671.45 INR

Financiële Gegevens

Cijfers zijn in miljoenen (INR)

Cijfers zijn in miljoenen (INR)